Literature DB >> 7538117

Adhesive interactions between alternatively spliced CD44 isoforms.

A Droll1, S T Dougherty, R K Chiu, J F Dirks, W H McBride, D L Cooper, G J Dougherty.   

Abstract

Alternative splicing of a series of 10 contiguous exons present within the CD44 gene can generate a large number of differentially expressed CD44 isoforms that contain additional peptide sequences of varying length inserted into a single site within the extracellular domain of the molecule proximal to the membrane spanning domain. Although distinct functions have been ascribed to certain of these isoforms, the effect of particular inserted domains on the ligand-binding specificity of the CD44 molecule remains unclear. In the present study, we demonstrate that while CD44H, the major CD44 isoform expressed on resting hemopoietic cells, and CD44R1, an alternatively spliced isoform present on transformed epithelial cells and certain activated and/or malignant hemopoietic cell types, can both bind avidly to hyaluronan, only CD44R1 can promote homotypic cellular aggregation when expressed in the CD44-negative murine lymphoma cell line TIL1. Experiments in which TIL1 cells transduced with different CD44 isoforms were tested for their ability to adhere to one another or to COS7 cells transfected with CD44R1, indicated that CD44R1 can recognize and bind a common determinant present on both CD44H and CD44R1. Monoclonal antibody blocking studies suggest further, that the determinant recognized by CD44R1 is located in a region of the CD44 molecule distinct from that involved in hyaluronan binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538117     DOI: 10.1074/jbc.270.19.11567

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.

Authors:  M Dohadwala; J Luo; L Zhu; Y Lin; G J Dougherty; S Sharma; M Huang; M Pold; R K Batra; S M Dubinett
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

Review 2.  Does DG42 synthesize hyaluronan or chitin?: A controversy about oligosaccharides in vertebrate development.

Authors:  A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

3.  CD44 isoform expression follows two alternative splicing pathways in breast tissue.

Authors:  X Roca; J L Mate; A Ariza; A M Muñoz-Mármol; C von Uexküll-Güldeband; I Pellicer; J J Navas-Palacios; M Isamat
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

4.  Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44.

Authors:  R K Chiu; A Droll; D L Cooper; S T Dougherty; J F Dirks; G J Dougherty
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

5.  Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.

Authors:  Y Guo; Y Wu; S Shinde; M S Sy; A Aruffo; Y Liu
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

6.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

7.  Differential killing of pre-B acute lymphoblastic leukaemia cells by activated NK cells and the NK-92 ci cell line.

Authors:  G S D Reid; S Bharya; H-G Klingemann; K R Schultz
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

8.  Two different functions for CD44 proteins in human myelopoiesis.

Authors:  J Moll; S Khaldoyanidi; J P Sleeman; M Achtnich; I Preuss; H Ponta; P Herrlich
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models.

Authors:  Dan Peer; Rimona Margalit
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

10.  High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones.

Authors:  Kwanghee Kim; Julianne M Pollard; Andrew J Norris; J Tyson McDonald; Yingli Sun; Ewa Micewicz; Kelly Pettijohn; Robert Damoiseaux; Keisuke S Iwamoto; James W Sayre; Brendan D Price; Richard A Gatti; William H McBride
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.